05
Feb
PARTNER OPPORTUNITY ALERT
Comments
A Spanish university has modified several phage proteins (Poll-N and UK-C) that have high specificity against Escherichia coli (E. coli), but not against other Gram-negative bacteria. They could be used in the case of contaminated food, cosmetics or water, or even in the treatment of diseases (infections) caused by E. coli.
Biotechnological or pharmaceutical companies interested in the commercial exploitation of the technology through license and/or technical cooperation agreements are sought
